Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Huey En Tzeng"'
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 6, Pp 505-513 (2023)
Objectives/Background: Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with high mortality. To date, there is no comprehensive population-based analysis of patients with AML in Asia, including Taiwan. Material and methods: T
Externí odkaz:
https://doaj.org/article/547b88474ac94885b23eadd28ac60e24
Autor:
Yun-Chi Wang, Jie-Long He, Chung-Lin Tsai, Huey-En Tzeng, Wen-Shin Chang, Shih-Han Pan, Li-Hsiou Chen, Chen-Hsien Su, Jiunn-Cherng Lin, Chih-Chiang Hung, Da-Tian Bau, Chia-Wen Tsai
Publikováno v:
Life, Vol 14, Iss 1, p 9 (2023)
Tissue inhibitor of metalloproteinase-2 (TIMP-2) is an endogenous inhibitor of matrix metalloproteinase-2 and is highly expressed in breast cancer (BC) cases at diagnosis. However, the genetic investigations for the association of TIMP-2 genotypes wi
Externí odkaz:
https://doaj.org/article/4921b4c4310042d7a8ef22ba4faa0773
Publikováno v:
Diagnostics, Vol 13, Iss 22, p 3424 (2023)
Central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) is relatively uncommon, occurring in approximately 5% of cases, with the majority of instances manifesting during relapse and often associated with poor prognoses. The
Externí odkaz:
https://doaj.org/article/6157431721a042ef9ee9843a7331f178
Autor:
Ruo-Kai Lin, Chih-Ming Su, Shih-Yun Lin, Le Thi Anh Thu, Phui-Ly Liew, Jian-Yu Chen, Huey-En Tzeng, Yun-Ru Liu, Tzu-Hao Chang, Cheng-Yang Lee, Chin-Sheng Hung
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-20 (2022)
Abstract Background Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and d
Externí odkaz:
https://doaj.org/article/c18ac44cbf4f4316a04a4f5d72dbce83
In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Targeting the programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) axis with monoclonal antibodies (mAbs) represents a crucial breakthrough in anticancer therapy, but mAbs are limited by their poor oral bioavailability
Externí odkaz:
https://doaj.org/article/7877ddfc07c5458ea9a7787b84758998
Autor:
Huey-En Tzeng, Syuan-Ling Lin, Louis Anoop Thadevoos, Ming-Yu Lien, Wei-Hung Yang, Chih-Yuan Ko, Chih-Yang Lin, Yu-Wen Huang, Ju-Fang Liu, Yi-Chin Fong, Hsien-Te Chen, Chih-Hsin Tang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 12, Pp 1-12 (2021)
Abstract Chondrosarcoma is a malignancy of soft tissue and bone that has a high propensity to metastasize to distant organs. Nerve growth factor (NGF) is critical for neuronal cell growth, apoptosis, and differentiation, and also appears to promote t
Externí odkaz:
https://doaj.org/article/4fcab6fdf7e64a368c815ac2f97733f3
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 31, Iss , Pp 689-690 (2023)
Externí odkaz:
https://doaj.org/article/c807822a98ad49d7956c40524aa391b7
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Controversy remains regarding the relationship between bone health and sleep. In the literature, the effect of sleep on bone density in the clinical setting varies depending on the definition of normal sleep duration, sleep quality, selected
Externí odkaz:
https://doaj.org/article/c07d9ab39878480d9b4e9cb6818071de
Autor:
Chin-Beng Ho, Jo-Ting Tsai, Chun-You Chen, Her-Shyong Shiah, Hsuan-Yu Chen, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Hsin-Yi Lai, Chi-Li Chung, Kai-Ling Lee, Huey-En Tzeng, Kuen-Haur Lee, Hsin-Lun Lee, Shang-Wen Chen, Jeng-Fong Chiou
Publikováno v:
Diagnostics, Vol 13, Iss 9, p 1597 (2023)
Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after systemic therapy on SABR outcomes remains unclear. Hence, we investiga
Externí odkaz:
https://doaj.org/article/6f9f9045cd914a84a5296d5170131708
Autor:
Jason C. Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, Szu-Chun Yang, Chien-Chung Lin, Yi-Hsin Yang, Yu-Chao Lin, Te-Chun Hsia, Hsing-Chun Hsieh, Jia-Syuan Wu, Chi-Pei Chang, Yin-Hsun Feng, Peng-Chan Lin, Ping-Chih Hsu, Huey-En Tzeng, Shu-Chen Chien, Wei-Chiao Chang, Chih-Cheng Chang, Hsuan-Chia Yang, Chueh Ming Lee, Christine Y. Lu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immune checkpoint inhibitors (ICIs) have been approved to treat patients with various cancer types, including lung cancer, in many countries. This study aims to investigate the effectiveness and safety of ICIs under different treatment conditions of
Externí odkaz:
https://doaj.org/article/4dd36ee8c51441eb9bd0030eb0748e82